Back to search
Primary Indolent Cutaneous B-cell Lymphoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Indolent Cutaneous B-cell Lymphoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Primary Indolent Cutaneous B-cell Lymphoma trials you may qualify forPrimary indolent cutaneous B cell lymphomas (PCBCL) are rare: although data on outcomes and treatment are limited, traditionally they have been treated with rad…
This phase II trial studies the effect of zanubrutinib and CAR T-cell therapy in treating patients with aggressive B-cell non-Hodgkin's lymphoma or transformed…